EUVIMEDEUVIMED entdecken
Crossref

LDHA facilitates immune escape in bladder cancer through H4K5 lactylation-dependent upregulation of PD-L1

Sensheng Tang, Yu Liu, Bo Jin, Tianyang Zhang, Xingbo Wang, Jie Zhao, Zhibin Xu, Wenchao Zhao, Hao Bian, Kai Li, Yuan Xia, Hui Wang und 1 weitere

Biochemical Pharmacology · 2026-01 · 243 · 117553

DOI: 10.1016/j.bcp.2025.117553 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026-01. Verfasst von Sensheng Tang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huaian, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, B7-H1 Antigen, Histones, Lactate Dehydrogenase 5. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Jiangsu Province Natural Science Foundation, Nanjing Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic reprogramming, characterized by hyperactive glycolysis, is a hallmark of bladder cancer (BCa) progression. Here, we identify lactate dehydrogenase A (LDHA) as a central metabolic node coupling glycolytic flux to epigenetic regulation of the immune checkpoint molecule PD-L1. Transcriptomic and survival analyses reveal that dysregulated glycolytic enzymes, particularly LDHA, correlate with poor prognosis and immunotherapy response in BCa patients. Mechanistically, LDHA-driven lactate production induces histone H4K5 lactylation (H4K5la), facilitated by the acetyltransferase EP300, which directly activates PD-L1 transcription. Depletion of LDHA or EP300 reduces H4K5la levels and suppresses PD-L1 expression. Critically, EP300 knockdown reverses PD-L1 upregulation induced by LDHA overexpression, establishing a causal LDHA-EP300-H4K5la-PD-L1 axis that drives immune evasion. Furthermore, RNA immunoprecipitation and luciferase reporter assays suggest that m6A RNA modification may potentiate LDHA overexpression. Collectively, this work unveils a dual-layered mechanism-metabolic lactate flux and histone lactylation that orchestrates immune evasion in BCa, proposing LDHA and EP300 as actionable targets to restore antitumor immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsB7-H1 AntigenHistonesLactate Dehydrogenase 5L-Lactate DehydrogenaseTumor EscapeHumansUp-RegulationCell Line, TumorAnimalsE1A-Associated p300 Protein

Stichwörter der Autor:innen

Bladder cancerHistone lactylationImmune escapeImmunotherapyLDHAPD-L1

Substanzen

B7-H1 AntigenCD274 protein, humanHistonesLDHA protein, humanLactate Dehydrogenase 5L-Lactate DehydrogenaseEP300 protein, humanE1A-Associated p300 Protein

Autor:innen und Institutionen

  • Department of Urology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huaian, China.
  • Department of Urology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, China; Department of Urology, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, China.
  • Department of Urology, Xuzhou Cancer Hospital Affiliated to Jiangsu University, Xuzhou Cancer Hospital, Xuzhou, China.
  • Department of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China. Electronic address: kaili98@njmu.edu.cn.
  • Department of Hematology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, China. Electronic address: xia816yuan@163.com.
  • Department of Urology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, China; Department of Urology, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, China. Elec…

Förderung

  • Jiangsu Province Natural Science Foundation
  • Nanjing Medical University

Zitieren

APA

Tang, S., Liu, Y., Jin, B., Zhang, T., Wang, X., Zhao, J., Xu, Z., Zhao, W., Bian, H., Li, K., Xia, Y., Wang, H., & Guo, M. (2026). LDHA facilitates immune escape in bladder cancer through H4K5 lactylation-dependent upregulation of PD-L1. Biochemical Pharmacology, 243, 117553. https://doi.org/10.1016/j.bcp.2025.117553

Vancouver

Tang S, Liu Y, Jin B, Zhang T, Wang X, Zhao J, et al. LDHA facilitates immune escape in bladder cancer through H4K5 lactylation-dependent upregulation of PD-L1. Biochemical Pharmacology. 2026;243:117553. doi:10.1016/j.bcp.2025.117553

BibTeX
@article{Tang2026,
  author = {Tang, Sensheng and Liu, Yu and Jin, Bo and Zhang, Tianyang and Wang, Xingbo and Zhao, Jie and Xu, Zhibin and Zhao, Wenchao and Bian, Hao and Li, Kai and Xia, Yuan and Wang, Hui and Guo, Maomao},
  title = {LDHA facilitates immune escape in bladder cancer through H4K5 lactylation-dependent upregulation of PD-L1},
  journal = {Biochemical Pharmacology},
  year = {2026},
  volume = {243},
  pages = {117553},
  doi = {10.1016/j.bcp.2025.117553}
}
Kostenlos starten →